In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 243 for your search:
Near ZIP Code:  within 100 miles of 78229
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Natural history/Epidemiology, Prevention
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: 1U01AG029824-01A2, NCT01038583

2.

Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672

3.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01987, RTOG-0848, CDR0000659092, U10CA021661, U10CA180868, NCT01013649

4.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 609, U01HL069294, BMT CTN 0801, U01HL069294-06, NCT01106833

5.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: ANHL1131, NCI-2012-01963, CDR0000732604, U10CA098543, COG-ANHL1131, NCT01595048

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3475-010, 2012-004391-19, 132355, NCT01905657

7.

Phase: Phase III
Type: Treatment
Status: Active
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000064184, SWOG-9346, CAN-NCIC-PR8, CALGB-9594, ECOG-S9346, EORTC-30985, CAN-NCIC-JPR8, INT-0162, PR8, NCT00002651

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-2009-01064, CDR0000069018, COG-ANBL0032, ANBL0032, U10CA098543, COG-P9842, NCT00026312

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: 020221, NCT00045968

10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000526353, CALGB-90203, NCT00430183

11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00587, CDR0000546714, GOG-0213, U10CA027469, NCT00565851

12.

Phase: Phase III
Type: Treatment
Status: Active
Age: 10 and under
Sponsor: NCI, Other
Protocol IDs: ARET0321, NCI-2009-00421, COG-ARET0321, CDR0000573987, U10CA098543, NCT00554788

13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0534, CDR0000577574, NCI-2009-00733, NCT00567580

14.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00507, CDR0000582533, E1305, U10CA180820, U10CA021115, ECOG-E1305, NCT00588770

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000582632, EORTC-26053, CAN-NCIC-CEC1, RTOG-0834, EORTC-22054, EUDRACT-2006-001533-17, SPRI-EORTC-26053, MERCK-EORTC-26053, MRC-BR14, COGNO-EORTC-26053, CEC1, NCT00626990

16.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000588879, CALGB-30610, RTOG 0538, U10CA031946, NCT00632853

17.

Phase: Phase III
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 12311, 2007-002604-17, NCT00625378

18.

Phase: Phase III
Type: Behavioral study, Biomarker/Laboratory analysis
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0225, NCI-2009-00595, CDR0000594600, U10CA101165, NCT00719303

19.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00702, CDR0000615085, NSABP B-43, U10CA180868, U10CA012027, NCT00769379

20.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20070782, NCT00858364

21.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0815, CDR0000648194, NCI-2011-01948, NCT00936390

22.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: Under 30 at initial diagnosis
Sponsor: NCI, Other
Protocol IDs: AREN0534, NCI-2011-01953, CDR0000649716, U10CA098543, COG-AREN0534, NCT00945009

23.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0920, CDR0000651536, NCI-2011-00878, NCT00956007

24.

Phase: Phase III
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: AHEP0731, NCI-2011-01975, CDR0000654889, COG-AHEP0731, U10CA098543, NCT00980460

25.

Phase: Phase III
Type: Tissue collection/Repository, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000668388, S0931, U10CA032102, SWOG-S0931, NCT01120249
1     
New Search